Penobscot Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.03M Sell
31,382
-25
-0.1% -$2.93K 0.28% 83
2026
Q1
$3.78M Sell
31,407
-202
-0.6% -$23.3K 0.3% 81
2025
Q4
$3.33M Sell
31,609
-225
-0.7% -$21.1K 0.25% 84
2025
Q3
$2.67M Buy
31,834
+995
+3% +$82K 0.21% 101
2025
Q2
$2.44M Sell
30,839
-8,886
-22% -$706K 0.21% 98
2025
Q1
$3.57M Buy
39,725
+3,561
+10% +$332K 0.34% 67
2024
Q4
$3.6M Sell
36,164
-5,225
-13% -$539K 0.33% 65
2024
Q3
$4.7M Buy
41,389
+3,433
+9% +$408K 0.42% 58
2024
Q2
$4.7M Buy
37,956
+425
+1% +$54.7K 0.45% 54
2024
Q1
$4.95M Buy
37,531
+955
+3% +$118K 0.52% 49
2023
Q4
$3.99M Buy
36,576
+648
+2% +$67.3K 0.47% 55
2023
Q3
$3.71M Buy
35,928
+14,975
+71% +$1.61M 0.5% 51
2023
Q2
$2.42M Buy
20,953
+264
+1% +$30K 0.4% 66
2023
Q1
$2.2M Sell
20,689
-4,293
-17% -$463K 0.38% 70
2022
Q4
$2.77M Hold
24,982
0.49% 57
2022
Q3
$2.15M Sell
24,982
-900
-3% -$80.3K 0.4% 70
2022
Q2
$2.36M Sell
25,882
-2,996
-10% -$266K 0.41% 68
2022
Q1
$2.37M Buy
28,878
+2,000
+7% +$158K 0.35% 77
2021
Q4
$2.06M Hold
26,878
0.28% 84
2021
Q3
$2.02M Sell
26,878
-1,110
-4% -$84.4K 0.3% 83
2021
Q2
$2.18M Sell
27,988
-5,290
-16% -$393K 0.32% 81
2021
Q1
$2.45M Sell
33,278
-2,110
-6% -$156K 0.39% 67
2020
Q4
$2.76M Buy
35,388
+3,559
+11% +$272K 0.46% 59
2020
Q3
$2.52M Hold
31,829
0.48% 53
2020
Q2
$2.35M Sell
31,829
-660
-2% -$49.7K 0.48% 57
2020
Q1
$2.38M Hold
32,489
0.56% 52
2019
Q4
$2.82M Sell
32,489
-367
-1% -$30.1K 0.53% 56
2019
Q3
$2.64M Sell
32,856
-3
-0% -$240 0.53% 59
2019
Q2
$2.63M Sell
32,859
-430
-1% -$32.9K 0.54% 57
2019
Q1
$2.64M Sell
33,289
-442
-1% -$33.1K 0.56% 57
2018
Q4
$2.46M Hold
33,731
0.59% 60
2018
Q3
$2.28M Hold
33,731
0.49% 64
2018
Q2
$1.95M Sell
33,731
-2,934
-8% -$166K 0.45% 68
2018
Q1
$1.91M Buy
36,665
+9,125
+33% +$493K 0.46% 68
2017
Q4
$1.48M Buy
27,540
+786
+3% +$43.6K 0.41% 71
2017
Q3
$1.63M Hold
26,754
0.49% 66
2017
Q2
$1.64M Buy
26,754
+188
+0.7% +$11.4K 0.53% 63
2017
Q1
$1.61M Sell
26,566
-230
-0.9% -$14K 0.54% 63
2016
Q4
$1.5M Sell
26,796
-642
-2% -$37.6K 0.52% 64
2016
Q3
$1.63M Buy
27,438
+2
+0% +$117 0.57% 58
2016
Q2
$1.51M Sell
27,436
-314
-1% -$16.7K 0.54% 63
2016
Q1
$1.4M Sell
27,750
-9,655
-26% -$473K 0.52% 63
2015
Q4
$1.89M Sell
37,405
-74
-0.2% -$3.73K 0.59% 58
2015
Q3
$1.77M Hold
37,479
0.59% 54
2015
Q2
$2.04M Sell
37,479
-79
-0.2% -$4.43K 0.63% 52
2015
Q1
$2.06M Hold
37,558
0.65% 50
2014
Q4
$2.04M Buy
37,558
+1,153
+3% +$64.2K 0.64% 51
2014
Q3
$2.06M Buy
36,405
+554
+2% +$31.1K 0.68% 49
2014
Q2
$1.98M Buy
35,851
+4,457
+14% +$243K 0.67% 52
2014
Q1
$1.7M Sell
31,394
-1,991
-6% -$103K 0.6% 55
2013
Q4
$1.59M Sell
33,385
-493
-1% -$22.5K 0.56% 59
2013
Q3
$1.54M Hold
33,878
0.6% 55
2013
Q2
$1.5M Buy
+33,878
New +$1.51M 0.63% 52

Other funds holding MRK

Penobscot Investment Management's MRK Position: Q2 2026 in Review

Penobscot Investment Management reduced its Merck (MRK) stake by 0.08% in Q2 2026, selling an estimated $2.93K and leaving 31,382 shares worth $4.03M. The position accounts for 0.28% of the portfolio, ranked #83.

Penobscot Investment Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.95M in Q1 2024. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Penobscot Investment Management held 31,382 shares of Merck worth $4.03M as of Q2 2026.
  • Penobscot Investment Management sold 25 Merck shares in Q2 2026, an estimated $2.93K.
  • Merck made up 0.28% of Penobscot Investment Management's portfolio in Q2 2026, its #83 holding.
  • Penobscot Investment Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Penobscot Investment Management's Merck position peaked at $4.95M in Q1 2024.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.